SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

AVROBIO, Inc. – ‘10-Q’ for 9/30/20 – ‘EX-3.2’

On:  Thursday, 11/5/20, at 5:05pm ET   ·   For:  9/30/20   ·   Accession #:  1564590-20-51456   ·   File #:  1-38537

Previous ‘10-Q’:  ‘10-Q’ on 8/6/20 for 6/30/20   ·   Next:  ‘10-Q’ on 5/13/21 for 3/31/21   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23   ·   23 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/05/20  AVROBIO, Inc.                     10-Q        9/30/20   61:6.1M                                   ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    972K 
 2: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     30K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
12: R1          Document and Entity Information                     HTML     77K 
13: R2          Condensed Consolidated Balance Sheets               HTML     84K 
14: R3          Condensed Consolidated Balance Sheets               HTML     36K 
                (Parenthetical)                                                  
15: R4          Condensed Consolidated Statements of Operations     HTML     55K 
                and Comprehensive Loss                                           
16: R5          Condensed Consolidated Statements of Stockholders'  HTML     92K 
                Equity                                                           
17: R6          Condensed Consolidated Statements of Stockholders'  HTML     23K 
                Equity (Parenthetical)                                           
18: R7          Condensed Consolidated Statements of Cash Flows     HTML     87K 
19: R8          Nature of the Business                              HTML     25K 
20: R9          Summary of Significant Accounting Policies          HTML     38K 
21: R10         Fair Value Measurement                              HTML     77K 
22: R11         Prepaid Expenses and Other Current Assets           HTML     45K 
23: R12         Property and Equipment, Net                         HTML     46K 
24: R13         Accrued Expenses and Other Current Liabilities      HTML     44K 
25: R14         Stockholders' Equity                                HTML     52K 
26: R15         Stock-Based Compensation                            HTML    137K 
27: R16         License Agreements                                  HTML     40K 
28: R17         Net Loss per Share Attributable to Common           HTML     34K 
                Stockholders                                                     
29: R18         Commitments and Contingencies                       HTML     26K 
30: R19         Related Party Transactions                          HTML     24K 
31: R20         Summary of Significant Accounting Policies          HTML     51K 
                (Policies)                                                       
32: R21         Fair Value Measurement (Tables)                     HTML     76K 
33: R22         Prepaid Expenses and Other Current Assets (Tables)  HTML     45K 
34: R23         Property and Equipment, Net (Tables)                HTML     45K 
35: R24         Accrued Expenses and Other Current Liabilities      HTML     44K 
                (Tables)                                                         
36: R25         Stockholders' Equity (Tables)                       HTML     53K 
37: R26         Stock-Based Compensation (Tables)                   HTML    142K 
38: R27         Net Loss per Share Attributable to Common           HTML     33K 
                Stockholders (Tables)                                            
39: R28         Nature of the Business - Additional Information     HTML     35K 
                (Detail)                                                         
40: R29         Summary of Significant Accounting Policies -        HTML     50K 
                Additional Information (Detail)                                  
41: R30         Fair Value Measurement - Summary of Financial       HTML     27K 
                Assets Measured at Fair Value on Recurring Basis                 
                (Detail)                                                         
42: R31         Fair Value Measurement - Additional Information     HTML     20K 
                (Detail)                                                         
43: R32         Prepaid Expenses and Other Current Assets -         HTML     32K 
                Summary of Prepaid Expenses and Other Current                    
                Assets (Detail)                                                  
44: R33         Property and Equipment, Net - Summary of Property   HTML     34K 
                and Equipment, Net (Detail)                                      
45: R34         Property and Equipment, Net - Additional            HTML     21K 
                Information (Detail)                                             
46: R35         Accrued Expenses and Other Current Liabilities -    HTML     33K 
                Summary of Accrued Expenses and Other Current                    
                Liabilities (Detail)                                             
47: R36         Stockholders' Equity - Additional Information       HTML     28K 
                (Detail)                                                         
48: R37         Stockholders' Equity - Summary of Common Stock      HTML     34K 
                Reserved for Future Issuance (Detail)                            
49: R38         Stock-Based Compensation - Summary of Assumptions   HTML     27K 
                that Used to Determine Grant-Date Fair Value of                  
                Stock Options Granted to Employees and Members of                
                Board of Directors (Detail)                                      
50: R39         Stock-Based Compensation - Summary of Stock Option  HTML     54K 
                Activity (Detail)                                                
51: R40         Stock-Based Compensation - Additional Information   HTML     33K 
                (Detail)                                                         
52: R41         Stock-Based Compensation - Summary of Restricted    HTML     30K 
                Stock Unit Activity (Detail)                                     
53: R42         Stock-Based Compensation - Schedule of Stock-based  HTML     27K 
                Compensation Expense (Detail)                                    
54: R43         License Agreements - Additional Information         HTML     92K 
                (Detail)                                                         
55: R44         Net Loss per Share Attributable to Common           HTML     26K 
                Stockholders - Schedule of Dilutive Common Stock                 
                Equivalents Excluded from Computation of Diluted                 
                Net Loss per Share (Detail)                                      
56: R45         Commitments and Contingencies - Additional          HTML     30K 
                Information (Detail)                                             
57: R46         Related Party Transactions - Additional             HTML     30K 
                information (Detail)                                             
59: XML         IDEA XML File -- Filing Summary                      XML    108K 
11: XML         XBRL Instance -- avro-10q_20200930_htm               XML   1.17M 
58: EXCEL       IDEA Workbook of Financial Reports                  XLSX     62K 
 7: EX-101.CAL  XBRL Calculations -- avro-20200930_cal               XML     89K 
 8: EX-101.DEF  XBRL Definitions -- avro-20200930_def                XML    251K 
 9: EX-101.LAB  XBRL Labels -- avro-20200930_lab                     XML    766K 
10: EX-101.PRE  XBRL Presentations -- avro-20200930_pre              XML    529K 
 6: EX-101.SCH  XBRL Schema -- avro-20200930                         XSD    123K 
60: JSON        XBRL Instance as JSON Data -- MetaLinks              227±   351K 
61: ZIP         XBRL Zipped Folder -- 0001564590-20-051456-xbrl      Zip    212K 


‘EX-3.2’   —   Articles of Incorporation/Organization or Bylaws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

Exhibit 3.2

STATE OF DELAWARE

CERTIFICATE OF CHANGE OF REGISTERED AGENT

AND/OR REGISTERED OFFICE

 

The corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows:

 

 

1.

The name of the corporation is AVROBIO, INC.                                                               .

 

 

2.

The Registered Office of the corporation in the State of Delaware is changed to

 

Corporation Trust Center,

 

1209 Orange Street

, in the City of

Wilmington                 .

 

County of New Castle    Zip Code 19801      . The name of the Registered Agent at such address upon whom process against this Corporation may be served is THE CORPORATION TRUST COMPANY                                                                   .

 

3.The foregoing change to the registered office/agent was adopted by a resolution of the Board of Directors of the corporation.

 

By:

 

/s/ Marcia Gookin

 

 

Authorized Officer

 

 

 

Name:

 

Marcia Gookin

 

 


 

STATE OF DELAWARE  

CERTIFICATE OF CORRECTION  

 

AVROBIO, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware.

 

DOES HEREBY CERTIFY:

 

1.

The name of the corporation is AVROBIO, Inc.                .

 

2.

That a Certificate of Change of Registered Agent was filed by the Secretary of State of Delaware on 9/9/2020 and that said Certificate requires correction as permitted by Section 103 of the General Corporation Law of the State of Delaware.

 

3.

The inaccuracy or defect of said Certificate is:

Certificate was not signed by an authorized officer.

Article Signature Block of the Certificate is corrected to read as follows:

 

Steven Avruch, Chief Legal Officer and Secretary

 

IN WITNESS WHEREOF, said corporation has caused this Certificate of Correction

 

this

 6th

day of

 October

, A.D.

2020

 

By:

 

/s/ Steven N. Avruch

Name:

 

Steven N. Avruch

Title:

 

Chief Legal Officer

 

 


21 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/24  AVROBIO, Inc.                     S-4/A                 91:17M                                    Donnelley … Solutions/FA
 3/26/24  AVROBIO, Inc.                     S-4/A       3/25/24   89:18M                                    Donnelley … Solutions/FA
 3/14/24  AVROBIO, Inc.                     10-K       12/31/23   80:9.4M                                   Donnelley … Solutions/FA
 2/14/24  AVROBIO, Inc.                     S-4                   91:25M                                    Donnelley … Solutions/FA
11/09/23  AVROBIO, Inc.                     10-Q        9/30/23   68:7.7M                                   Donnelley … Solutions/FA
 8/10/23  AVROBIO, Inc.                     10-Q        6/30/23   69:9.5M                                   Donnelley … Solutions/FA
 5/11/23  AVROBIO, Inc.                     10-Q        3/31/23   64:6.9M                                   Donnelley … Solutions/FA
 3/23/23  AVROBIO, Inc.                     S-8         3/23/23    4:65K                                    Broadridge Fin’l So… Inc
 3/23/23  AVROBIO, Inc.                     10-K       12/31/22   82:10M                                    Donnelley … Solutions/FA
11/08/22  AVROBIO, Inc.                     10-Q        9/30/22   64:7.2M                                   Donnelley … Solutions/FA
 8/09/22  AVROBIO, Inc.                     10-Q        6/30/22   65:7.3M                                   Donnelley … Solutions/FA
 5/10/22  AVROBIO, Inc.                     10-Q        3/31/22   64:5.9M                                   ActiveDisclosure/FA
 3/17/22  AVROBIO, Inc.                     10-K       12/31/21   78:9.1M                                   ActiveDisclosure/FA
 3/17/22  AVROBIO, Inc.                     S-8         3/17/22    4:62K                                    Donnelley … Solutions/FA
11/04/21  AVROBIO, Inc.                     10-Q        9/30/21   58:6.8M                                   ActiveDisclosure/FA
 8/05/21  AVROBIO, Inc.                     10-Q        6/30/21   55:5.8M                                   ActiveDisclosure/FA
 5/13/21  AVROBIO, Inc.                     10-Q        3/31/21   62:5.3M                                   ActiveDisclosure/FA
 3/18/21  AVROBIO, Inc.                     10-K       12/31/20   73:9.1M                                   ActiveDisclosure/FA
 3/18/21  AVROBIO, Inc.                     S-8         3/18/21    3:81K                                    Donnelley … Solutions/FA
11/20/20  AVROBIO, Inc.                     424B5                  1:5.2M                                   Donnelley … Solutions/FA
11/19/20  AVROBIO, Inc.                     424B5                  1:5.1M                                   Donnelley … Solutions/FA


2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/06/20  AVROBIO, Inc.                     10-Q        6/30/20   60:6.4M                                   ActiveDisclosure/FA
 6/25/18  AVROBIO, Inc.                     8-K:5,9     6/20/18    3:148K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001564590-20-051456   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 6:37:48.2am ET